8000 MARINA BOULEVARD, SUITE 120, BRISBANE, CA
Investor Presentation
Provides Business Update and Reports Second Quarter 2026 Financial Results
William Turner Transitions to Special Advisor; Nancy Bowman Named CRO
Other Events
Vera Therapeutics, Inc. Elects Three Class II Directors at Annual Meeting
Provides Business Update and Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Amended Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
S-1MEF